Clinical Trials · NCT01006889
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Florida
- Enrollment
- 24
- Start date
- Jan 2008
- Locations
- 1 site, United States
- Primary endpoint
- Hepatic Steatosis